CAS: 331731-18-1 - ImmunoglobulinG1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain),disulfide with human monoclonal D2E7 light chain, dimer
- Sinonimi:
- Adalimumab
- D 2E7
- Humira
- Unii-fys6T7F842
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Adalimumab REF: TM-T9901CAS: 331731-18-1 | 95% - 99.50% | 199,00 €~1.051,00 € | Mer 29 Gen 25 |
 | Adalimumab REF: 3D-FI139131CAS: 331731-18-1 | Min. 95% | 745,00 €~4.555,00 € | Mer 05 Mar 25 |
Adalimumab
CAS:331731-18-1
Adalimumab (anti-TNF-alpha) is the first fully human recombinant IgG1 monoclonal antibody that specifically targets human …
Purezza:
95% - 99.50%
Colore e forma:
Liquid
Peso molecolare:
145.4 kDa
Ref: TM-T9901
| 1mg | 199,00 € | ||
| 5mg | 417,00 € | ||
| 10mg | 662,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 29 Gennaio 2025
Adalimumab
CAS:331731-18-1
Adalimumab is a monoclonal antibody that binds to TNF-α, a proinflammatory cytokine. It is used …
Formula:
C6428H9912N1694O1987S46
Purezza:
Min. 95%
Colore e forma:
Clear Liquid
Peso molecolare:
144099.37971
Ref: 3D-FI139131
| 1mg | 745,00 € | ||
| 2mg | 904,00 € | ||
| 5mg | 1.336,00 € | ||
| 10mg | 2.369,00 € | ||
| 25mg | 4.555,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 05 Marzo 2025
